PAFAH1B3 and neoplasm: As shown in Figures 1A, B, PAFAH1B3 was significantly overexpressed in osteosarcoma tumor samples (62.7%, 52/83), but was hardly measured in the matching non-tumor tissues (22.7%, 10/44) (P < 0.01).